ST. LOUIS, Nov. 13, 2024 (GLOBE NEWSWIRE) — Curium, a world leader in nuclear medicine, announced today that its ECLIPSE trial met its primary endpoint. ECLIPSE is a pivotal Phase 3, multi-center, ...
Copper hydroxide forms a blue precipitate. The table shows the coloured precipitates formed by five common metal ions in this test.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback